U.S. market Closed. Opens in 2 hours 8 minutes

LEGN | Legend Biotech Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue285.14M117.00M89.79M75.68M57.26M49.13M
Cost of Revenue164.66M65.36M313.35M232.16MN/AN/A
Gross Profit120.48M51.64M-223.55M-156.48M57.26M49.13M
Operating Expenses562.69M509.70M462.83M304.88M192.63M64.20M
Selling, General & Admin180.48M174.05M149.48M72.72M32.37M3.93M
Research & Development382.22M335.65M313.35M232.16M161.94M60.64M
Other Operating Expenses-28.24M2.23M-6.07M-74.21M-1.68M-2.00K
Operating Income-442.22M-455.83M-393.02M-313.35M-130.87M-1.53M
Other Expenses / Income-77.90M10.10M6.82M5.72M501.00K7.32M
Before Tax Income-520.12M-445.72M-386.21M-307.62M-130.37M-1.62M
Income Tax Expenses-1.86M625.00K1.00K-4.14M2.60M1.17M
Net Income-518.25M-446.35M-386.21M-303.48M-132.97M-2.78M
Interest Expenses21.79M10.80M900.00K4.21M223.00K82.00K
Basic Shares Outstanding176.08M159.04M140.85M118.15M132.01M100.21M
Diluted Shares Outstanding176.08M159.04M140.85M118.15M132.01M100.21M
EBITDA-421.76M-437.44M-379.11M-303.41M-125.61M-7.18M
EBITDA Margin-147.91%-373.86%-422.21%-400.94%-219.35%-14.61%
EBIT-498.32M-434.93M-385.31M-303.41M-130.15M-1.53M
EBIT Margin-174.76%-371.72%-429.11%-400.94%-227.28%-3.12%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙